Evidence map›Paper›PMID 26276874›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

DNA Methylation Regulates the Differential Expression of CX3CR1 on Human IL-7Rαlow and IL-7Rαhigh Effector Memory CD8+ T Cells with Distinct Migratory Capacities to the Fractalkine.

Min Sun Shin, Sungyong You, Youna Kang, Naeun Lee, Seung-Ah Yoo, Kieyoung Park, Ki Soo Kang, Sang Hyun Kim, Subhasis Mohanty, Albert C Shaw and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Expression of IL-7RαPediatric gastroenterology, hepatology & nutrition · 2024
    Article
  4. Mucosal Immunity Related to CD8Pediatric gastroenterology, hepatology & nutrition · 2024
    Article
  5. Aging gene signature of memory CD8Immunity & ageing : I & A · 2023
    Article
  6. Type-2 CD8Nature communications · 2023
    Article
  7. T cells in health and disease.Signal transduction and targeted therapy · 2023
    Review
  8. The Crossroads of Cancer Epigenetics and Immune Checkpoint Therapy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Epigenetic strategies to boost CAR T cell therapy.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Review
  15. Effector Memory CD8Pediatric gastroenterology, hepatology & nutrition · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Min Sun ShinDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520;
Sungyong YouDivision of Cancer Biology and Therapeutics, Department of Surgery, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048; Division of Cancer Biology and Therapeutics, Department of Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048; Division of Cancer Biology and Therapeutics, Department of Pathology and Laboratory Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048;
Youna KangDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520;
Naeun LeeDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520;
Seung-Ah YooDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520;
Kieyoung ParkDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520; Department of Pediatrics, College of Medicine, Ulsan University, Ulsan 680-749, Republic of Korea;
Ki Soo KangDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520; Department of Pediatrics, Jeju National University School of Medicine, Jeju 690-756, Republic of Korea;
Sang Hyun KimDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520; Department of Microbiology, College of Medicine, Kangwon National University, Chuncheon 200-701, Republic of Korea;
Subhasis MohantyDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520;
Albert C ShawDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520;
Ruth R MontgomeryDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520;
Daehee HwangSchool of Interdisciplinary Bioscience and Bioengineering, POSTECH, Pohang 790-784, Republic of Korea; and Department of New Biology and Center for Plant Aging Research, Institute for Basic Science, Daegu Gyeongbuk Institute of Science & Technology, Daegu, 711-873, Republic of Korea.
Insoo KangDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520; Insoo.kang@yale.edu.
Yale University · USCedars-Sinai Medical Center · USDaegu Gyeongbuk Institute of Science and Technology · KRJeju National University Hospital · KR

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
Systems investigation of vaccine responses in B cell depleted autoimmune patientsU19AI089992 · NIAID · YALE UNIVERSITY · PI David A. Hafler, RUTH R MONTGOMERY · 2010 to 2026
$50.4M
Midcareer Award in Translational Immunology of AgingK24AG042489 · NIA · YALE UNIVERSITY · PI SHAW, ALBERT C · 2012 to 2022
$1.8M
Aging and IL-7-mediated CD8+ T Cell survivalR01AG028069 · NIA · YALE UNIVERSITY · PI KANG, INSOO · 2007 to 2011
$1.6M
Aging and IL-7-Mediated CD8+ T Cell SurvivalR56AG028069 · NIA · YALE UNIVERSITY · PI KANG, INSOO · 2015 to 2015
$416k
Investigating aging and membrane-associated T cell receptor signaling in human CDR21AG030834 · NIA · YALE UNIVERSITY · PI KANG, INSOO · 2007 to 2008
$268k
NCRR NIH HHS UL1 RR024139NCRR NIH HHS UL1RR024139NIAID NIH HHS HHSN272201100019CNIAID NIH HHS U19 AI089992NIA NIH HHS AG028069NIA NIH HHS AG030834NIA NIH HHS K24 AG042489NIA NIH HHS R01 AG028069NIA NIH HHS R21 AG030834NIA NIH HHS R56 AG028069PHS HHS 272201100019C-3-0-1
6 · The paper itself

Abstract

DNA methylation is an epigenetic mechanism that modulates gene expression in mammalian cells including T cells. Memory T cells are heterogeneous populations. Human effector memory (EM) CD8(+) T cells in peripheral blood contain two cell subsets with distinct traits that express low and high levels of the IL-7Rα. However, epigenetic mechanisms involved in defining such cellular traits are largely unknown. In this study, we use genome-wide DNA methylation and individual gene expression to show the possible role of DNA methylation in conferring distinct traits of chemotaxis and inflammatory responses in human IL-7Rα(low) and IL-7Rα(high) EM CD8(+) T cells. In particular, IL-7Rα(low) EM CD8(+) T cells had increased expression of CX3CR1 along with decreased DNA methylation in the CX3CR1 gene promoter compared with IL-7Rα(high) EM CD8(+) T cells. Altering the DNA methylation status of the CX3CR1 gene promoter changed its activity and gene expression. IL-7Rα(low) EM CD8(+) T cells had an increased migratory capacity to the CX3CR1 ligand fractalkine compared with IL-7Rα(high) EM CD8(+) T cells, suggesting an important biological outcome of the differential expression of CX3CR1. Moreover, IL-7Rα(low) EM CD8(+) T cells induced fractalkine expression on endothelial cells by producing IFN-γ and TNF-α, forming an autocrine amplification loop. Overall, our study shows the role of DNA methylation in generating unique cellular traits in human IL-7Rα(low) and IL-7Rα(high) EM CD8(+) T cells, including differential expression of CX3CR1, as well as potential biological implications of this differential expression.

Indexed as

CD8-Positive T-LymphocytesCell AdhesionCells, CulturedChemokine CX3CL1ChemotaxisCX3C Chemokine Receptor 1DNA MethylationHumansImmunologic MemoryInterferon-gammaPromoter Regions, GeneticReceptors, ChemokineReceptors, Interleukin-7T-Lymphocyte SubsetsTumor Necrosis Factor-alphaChemokine CX3CL1CX3C Chemokine Receptor 1CX3CR1 protein, humanInterferon-gammainterleukin-7 receptor, alpha chainReceptors, ChemokineReceptors, Interleukin-7Tumor Necrosis Factor-alpha

Identifiers

PMID26276874
PMCPMC4561204
OpenAlexW2128528263

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.